These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22398065)

  • 1. Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
    Mooiweer E; Baars JE; Lutgens MW; Vleggaar F; van Oijen M; Siersema PD; Kuipers EJ; van der Woude CJ; Oldenburg B
    J Crohns Colitis; 2012 May; 6(4):435-40. PubMed ID: 22398065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
    Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
    Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
    Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
    Ali RA; Dooley C; Comber H; Newell J; Egan LJ
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
    Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
    J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.
    Söderlund S; Brandt L; Lapidus A; Karlén P; Broström O; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2009 May; 136(5):1561-7; quiz 1818-9. PubMed ID: 19422077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
    Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
    Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.